Last updated November 12, 2025 at 7:45 AM
Chapter 4729:9-1 | Controlled Substance Schedules
| Rule |
|---|
|
Rule 4729:9-1-01 | Schedule I controlled substances.
|
|
Rule 4729:9-1-02 | Schedule II controlled substances.
Pursuant to section 3719.41 of the Revised Code, controlled substance schedule II is hereby established, which schedules include the following, subject to amendment pursuant to section 3719.43 or 3719.44 of the Revised Code. (A) Narcotics-opium and opium derivatives Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis: (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene, naloxegol, naloxone, and naltrexone, and their respective salts, but including the following: (a) Raw opium; (b) Opium extracts; (c) Opium fluid extracts; (d) Powdered opium; (e) Granulated opium; (f) Tincture of opium; (g) Codeine; (h) Dihydroetorphine; (i) Ethylmorphine; (j) Etorphine hydrochloride; (k) Hydrocodone; (l) Hydromorphone; (m) Metopon; (n) Morphine; (o) Noroxymorphone; (p) Oripavine; (q) Oxycodone; (r) Oxymorphone; (s) Thebaine. (2) Any salt, compound, derivative, or preparation thereof that is chemically equivalent to or identical with any of the substances referred to in paragraph (A)(1) of this rule, except that these substances shall not include the isoquinoline alkaloids of opium; (3) Opium poppy and poppy straw; (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves (including cocaine and ecgonine, their salts, isomers, and derivatives, and salts of those isomers and derivatives), and any salt, compound, derivative, or preparation thereof that is chemically equivalent to or identical with any of these substances, except that the substances shall not include: (a) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or (b) [123I]ioflupane. (5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form that contains the phenanthrene alkaloids of the opium poppy). (B) Narcotics-opiates Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, but excluding dextrorphan and levopropoxyphene: (1) Alfentanil; (2) Alphaprodine; (3) Anileridine; (4) Bezitramide; (5) Bulk dextropropoxyphene (non-dosage forms); (6) Carfentanil; (7) Dihydrocodeine; (8) Diphenoxylate; (9) Fentanyl; (10) Isomethadone; (11) Levo-alphacetylmethadol (some other names: levo-alpha-acetylmethadol; levomethadyl acetate; LAAM); (12) Levomethorphan; (13) Levorphanol; (14) Metazocine; (15) Methadone; (16) Methadone-intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane; (17) Moramide-intermediate, 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid; (18) Pethidine (meperidine); (19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine; (20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate; (21) Pethidine-intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid; (22) Phenazocine; (23) Piminodine; (24) Racemethorphan; (25) Racemorphan; (26) Remifentanil; (27) Sufentanil; (28) Tapentadol; (29) Thiafentanil. (C) Stimulants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system: (1) Amphetamine, its salts, its optical isomers, and salts of its optical isomers; (2) Methamphetamine, its salts, its isomers, and salts of its isomers; (3) Methylphenidate; (4) Phenmetrazine and its salts; (5) Lisdexamfetamine, its salts, isomers, and salts of its isomers. (D) Depressants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Amobarbital; (2) Glutethimide; (3) Pentobarbital; (4) Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)piperidine; PCP); (5) Secobarbital; (6) 1-aminophenylcyclohexane and all N-mono-substituted and/or all N-N-disubstituted analogs including, but not limited to, the following: (a) 1-phenylcyclohexylamine; (b) (1-phenylcyclohexyl) methylamine; (c) (1-phenylcyclohexyl) dimethylamine; (d) (1-phenylcyclohexyl) methylethylamine; (e) (1-phenylcyclohexyl) isopropylamine; (f) 1-(1-phenylcyclohexyl) morpholine. (E) Hallucinogenic substances (1) Nabilone (another name for nabilone: (+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1- hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one); (2) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a dangerous drug approved for marketing by the U.S. food and drug administration. (F) Immediate precursors Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances: (1) Immediate precursor to amphetamine and methamphetamine: Phenylacetone (some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone); (2) Immediate precursors to phencyclidine (PCP): (a) 1-phenylcyclohexylamine; (b) 1-piperidinocyclohexanecarbonitrile (PCC). (3) Immediate precursor to fentanyl: 4-anilino-N-phenethylpiperidine (ANPP). Last updated May 6, 2024 at 9:51 AM Supplemental Information |
|
Rule 4729:9-1-03 | Schedule III controlled substances.
Pursuant to section 3719.41 of the Revised Code, controlled substance schedule III is hereby established, which schedules include the following, subject to amendment pursuant to section 3719.43 or 3719.44 of the Revised Code. (A) Stimulants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, their optical isomers, position isomers, or geometric isomers, and salts of these isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) All stimulant compounds, mixtures, and preparations included in schedule III pursuant to the federal drug abuse control laws and regulations adopted under those laws; (2) Benzphetamine; (3) Chlorphentermine; (4) Clortermine (5) Phendimetrazine. (B) Depressants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system: (1) Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs, and one or more other active medicinal ingredients that are not listed in any schedule; (2) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the food and drug administration for marketing only as a suppository; (3) Any substance that contains any quantity of a derivative of barbituric acid or any salt of a derivative of barbituric acid; (4) Chlorhexadol; (5) Embutramide; (6) Any dangerous drug containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act (8/20/2019); (7) Ketamine, its salts, isomers, and salts of isomers (some other names for ketamine: (+/-)-2-(2- chlorophenyl)-2-(methylamino)-cyclohexanone); (8) Lysergic acid; (9) Lysergic acid amide; (10) Methyprylon; (11) Sulfondiethylmethane; (12) Sulfonethylmethane; (13) Sulfonmethane; (14) Tiletamine, zolazepam, or any salt of tiletamine or zolazepam (some trade or other names for a tiletamine-zolazepam combination product: Telazol); (some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some trade or other names for zolazepam: 4-(2- fluorophenyl)-6,8- dihydro-1,3,8-trimethylpyrazolo-[3, 4-e][1,4]-diazepin-7(1H)-one; flupyrazapon); (15) Xylazine. (C) Narcotic antidotes Nalorphine. (D) Narcotics-narcotic preparations Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (1) Not more than 1.8 grams of codeine per one hundred milliliters or not more than ninety milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium; (2) Not more than 1.8 grams of codeine per one hundred milliliters or not more than ninety milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (3) Not more than 1.8 grams of dihydrocodeine per one hundred milliliters or not more than ninety milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (4) Not more than three hundred milligrams of ethylmorphine per one hundred milliliters or not more than fifteen milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5) Not more than five hundred milligrams of opium per one hundred milliliters or per one hundred grams or not more than twenty-five milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (6) Not more than fifty milligrams of morphine per one hundred milliliters or per one hundred grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (7) Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, set forth as follows: Buprenorphine. (E) Anabolic steroids (1) Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts, esters, isomers, and salts of esters and isomers, whenever the existence of these salts, esters, and isomers is possible within the specific chemical designation. (2) Anabolic steroids. Except as otherwise provided in paragraph (E)(1) of this rule, "anabolic steroids" means any drug or hormonal substance that is chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) and that promotes muscle growth. "Anabolic steroids" does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the United States secretary of health and human services for that administration, unless a person prescribes, dispenses, or distributes this type of anabolic steroid for human use. "Anabolic steroid" includes, but is not limited to, the following: (a) 3beta,17-dihydroxy-5a-androstane; (b) 3alpha,17beta-dihydroxy-5a-androstane; (c) 5alpha-androstan-3,17-dione; (d) 1-androstenediol (3beta,17beta-dihydroxy-5a-androst-1-ene); (e) 1-androstenediol (3alpha,17beta-dihydroxy-5a-androst-1-ene); (f) 4-androstenediol (3beta,17beta-dihydroxy-androst-4-ene); (g) 5-androstenediol (3beta,17beta-dihydroxy-androst-5-ene); (h) 1-androstenedione ([5alpha]-androst-1-en-3,17-dione); (i) 4-androstenedione (androst-4-en-3,17-dione); (j) 5-androstenedione (androst-5-en-3,17-dione); (k) Bolasterone (7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (l) Boldenone (17beta-hydroxyandrost-1,4-diene-3-one); (m) Boldione (androsta-1,4-diene-3,17-dione); (n) Calusterone (7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (o) Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one); (p) Dehydrochloromethyltestosterone (4-chloro-17beta-hydroxy-17alpha-methyl-androst-1,4-dien-3-one); (q) Desoxymethyltestosterone (17alpha-methyl-5alpha-androst-2-en-17beta-ol) (a.k.a. 'madol'); (r) Delta 1-dihydrotestosterone (a.k.a.'1-testosterone') (17beta-hydroxy-5alpha-androst-1-en-3-one); (s) 4-dihydrotestosterone (17beta-hydroxy-androstan-3-one); (t) Drostanolone (17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one); (u) Ethylestrenol (17alpha-ethyl-17beta-hydroxyestr-4-ene); (v) Fluoxymesterone (9-fluoro-17alpha-methyl-11beta,17beta-dihydroxyandrost-4-en-3-one); (w) Formebolone (2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1,4-dien-3-one); (x) Furazabol (17alpha-methyl-17beta-hydroxyandrostano[2,3-c]-furazan); (y) 13beta-ethyl-17beta-hydroxygon-4-en-3-one; (z) 4-hydroxytestosterone (4,17beta-dihydroxy-androst-4-en-3-one); (aa) 4-hydroxy-19-nortestosterone (4,17beta-dihydroxy-estr-4-en-3-one); (bb) Mestanolone (17alpha-methyl-17beta-hydroxy-5-androstan-3-one); (cc) Mesterolone (1alpha-methyl-17beta-hydroxy-[5alpha]-androstan-3-one); (dd) Methandienone (17alpha-methyl-17beta-hydroxyandrost-1,4-dien-3-one); (ee) Methandriol (17alpha-methyl-3beta,17beta-dihydroxyandrost-5-ene); (ff) Methasterone (2alpha,17alpha-dimethyl-5alpha-androstan-17beta-ol-3-one); (gg) Methenolone (1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one); (hh) 17alpha-methyl-3beta,17beta-dihydroxy-5a-androstane; (ii) 17alpha-methyl-3alpha,17beta-dihydroxy-5a-androstane; (jj) 17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene; (kk) 17alpha-methyl-4-hydroxynandrolone (17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one); (ll) Methyldienolone (17alpha-methyl-17beta-hydroxyestra-4,9(10)-dien-3-one); (mm) Methyltrienolone (17alpha-methyl-17beta-hydroxyestra-4,9,11-trien-3-one); (nn) Methyltestosterone (17alpha-methyl-17beta-hydroxyandrost-4-en-3-one); (oo) Mibolerone (7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-en-3-one); (pp) 17alpha-methyl-delta1-dihydrotestosterone (17beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) (a.k.a. '17-alpha-methyl-1-testosterone'); (qq) Nandrolone (17beta-hydroxyestr-4-en-3-one); (rr) 19-nor-4-androstenediol (3beta, 17beta-dihydroxyestr-4-ene); (ss) 19-nor-4-androstenediol (3alpha, 17beta-dihydroxyestr-4-ene); (tt) 19-nor-5-androstenediol (3beta, 17beta-dihydroxyestr-5-ene); (uu) 19-nor-5-androstenediol (3alpha, 17beta-dihydroxyestr-5-ene); (vv) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione); (ww) 19-nor-4-androstenedione (estr-4-en-3,17-dione); (xx) 19-nor-5-androstenedione (estr-5-en-3,17-dione); (yy) Norbolethone (13beta, 17alpha-diethyl-17beta-hydroxygon-4-en-3-one); (zz) Norclostebol (4-chloro-17beta-hydroxyestr-4-en-3-one); (aaa) Norethandrolone (17alpha-ethyl-17beta-hydroxyestr-4-en-3-one); (bbb) Normethandrolone (17alpha-methyl-17beta-hydroxyestr-4-en-3-one); (ccc) Oxandrolone (17alpha-methyl-17beta-hydroxy-2-oxa-[5alpha]-androstan-3-one); (ddd) Oxymesterone (17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one); (eee) Oxymetholone (17alpha-methyl-2-hydroxymethylene-17beta-hydroxy-[5alpha]-androstan-3-one); (fff) Prostanozol (17beta-hydroxy-5alpha-androstano[3,2-c]pyrazole); (ggg) Stanozolol (17alpha-methyl-17beta-hydroxy-[5alpha]-androst-2-eno[3,2-c]-pyrazole); (hhh) Stenbolone (17beta-hydroxy-2-methyl-[5alpha]-androst-1-en-3-one); (iii) Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone); (jjj) Testosterone (17beta-hydroxyandrost-4-en-3-one); (kkk) Tetrahydrogestrinone (13beta, 17alpha-diethyl-17beta-hydroxygon-4,9,11-trien-3-one); (lll) Trenbolone (17beta-hydroxyestr-4,9,11-trien-3-one); (mmm) Methandranone; (nnn) Any salt, ester, isomer, or salt of an ester or isomer of a drug or hormonal substance described or listed in paragraph (E)(2) of this rule if the salt, ester, or isomer promotes muscle growth. (F) Hallucinogenic substances Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved drug product (some other names for dronabinol: (6aR-trans)- 6a,7,8,10a-tetrahydro- 6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or (-)-delta-9-(trans)- tetrahydrocannabinol). Last updated May 6, 2024 at 9:51 AM Supplemental Information |
|
Rule 4729:9-1-04 | Schedule IV controlled substances.
Pursuant to section 3719.41 of the Revised Code, controlled substance schedule IV is hereby established, which schedules include the following, subject to amendment pursuant to section 3719.43 or 3719.44 of the Revised Code. (A) Narcotic drugs Unless specifically excepted by federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities set forth as follows: (1) Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit; (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2- propionoxybutane)[final dosage forms]; (3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol). (B) Depressants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Alfaxalone; (2) Alprazolam; (3) Barbital; (4) Brexanolone; (5) Bromazepam; (6) Camazepam; (7) Carisoprodol; (8) Chloral betaine; (9) Chloral hydrate; (10) Chlordiazepoxide; (11) Clobazam; (12) Clonazepam; (13) Clorazepate; (14) Clotiazepam; (15) Cloxazolam; (16) Delorazepam; (17) Diazepam; (18) Dichloralphenazone; (19) Estazolam; (20) Ethchlorvynol; (21) Ethinamate; (22) Ethyl loflazepate; (23) Fludiazepam; (24) Flunitrazepam; (25) Flurazepam; (26) Fospropofol; (27) Halazepam; (28) Haloxazolam; (29) Ketazolam; (30) Loprazolam; (31) Lorazepam; (32) Lormetazepam; (33) Mebutamate; (34) Medazepam; (35) Meprobamate; (36) Methohexital; (37) Methylphenobarbital (mephobarbital); (38) Midazolam; (39) Nimetazepam; (40) Nitrazepam; (41) Nordiazepam; (42) Oxazepam; (43) Oxazolam; (44) Paraldehyde; (45) Petrichloral; (46) Phenobarbital; (47) Pinazepam; (48) Prazepam; (49) Quazepam; (50) Suvorexant; (51) Temazepam; (52) Tetrazepam; (53) Triazolam; (54) Zaleplon; (55) Zolpidem; (56) Zopiclone. (C) Lorcaserin Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible: Lorcaserin. (D) Stimulants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, their optical isomers, position isomers, or geometric isomers, and salts of these isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Mazindol; (6) Mefenorex; (7) Modafinil; (8) Pemoline (including organometallic complexes and chelates thereof); (9) Phentermine; (10) Pipradrol; (11) Sibutramine; (12) Solriamfetol (2-amino-3-phenylpropyl car-bamate; benzenepropanol, beta-amino-, carbamate (ester)); (13) SPA [(-)-1-dimethylamino-1,2-diphenylethane]. (E) Other substances Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts: (1) Pentazocine; (2) Butorphanol (including its optical isomers); (3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1- (4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers. Last updated September 6, 2024 at 8:19 AM Supplemental Information |
|
Rule 4729:9-1-05 | Schedule V controlled substances.
Pursuant to section 3719.41 of the Revised Code, controlled substance schedule V is hereby established, which schedules include the following, subject to amendment pursuant to section 3719.43 or 3719.44 of the Revised Code. (A) Narcotics-narcotic preparations Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound, mixture, or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, and that includes one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone: (1) Not more than two hundred milligrams of codeine per one hundred milliliters or per one hundred grams; (2) Not more than one hundred milligrams of dihydrocodeine per one hundred milliliters or per one hundred grams; (3) Not more than one hundred milligrams of ethylmorphine per one hundred milliliters or per one hundred grams; (4) Not more than 2.5 milligrams of diphenoxylate and not less than twenty-five micrograms of atropine sulfate per dosage unit; (5) Not more than one hundred milligrams of opium perone hundred milliliters or per one hundred grams; (6) Not more than 0.5 milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit. (B) Stimulants Unless specifically exempted or excluded under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers, and salts of isomers: (1) Ephedrine, except as provided in division (K) of section 3719.44 of the Revised Code; (2) Pyrovalerone. (C) United States food and drug administration approved cannabidiol drugs Unless specifically exempted or excluded under federal drug abuse control laws or unless listed in another schedule, any drug product in finished dosage formulation that has been approved by the United States food and drug administration that contains cannabidiol (2-[1R-3-methyl-6R-(1- methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from cannabis and not more than 0.1 per cent (w/w) residual tetrahydrocannabinols. (D) Depressants Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts: (1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts); (2) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]; (3) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]; and (4) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]. Last updated May 6, 2024 at 9:51 AM Supplemental Information |